Issues
-
Cover Image
Cover Image
Inhibiting autophagy during interleukin-2 immunotherapy. Autophagic flux and diminished apoptosis are noted in established tumor cell lines, conferring resistance to chemotherapy, radiation therapy, and immunotherapy with interleukin 2. Chloroquine administration in vivo or, as shown here, in vitro can inhibit this process by preventing fusion of the autophagosome with the lysosome, allowing accumulation in the cytosol. Murine MC38 colorectal adenocarcinoma tumor cells were cultured and treated with 200 μM chloroquine for four hours. Immunofluorescence staining was done for LC3-II (green), actin (phalloidin; red) and nuclei (DAPI; blue). Chloroquine increased LC3-II puncta in both the MC38 tumor as well as the murine pancreatic adenocarcinoma Panc02 cells (not shown). For details, see article by Liang and colleagues on page 2791 of this issue. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Breaking Advances
Reviews
Priority Reports
Clinical Studies
Nanocytology of Rectal Colonocytes to Assess Risk of Colon Cancer Based on Field Cancerization
Integrated Systems and Technologies
Microenvironment and Immunology
Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
Cancer-Induced Immunosuppression: IL-18–Elicited Immunoablative NK Cells
CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression
Molecular and Cellular Pathobiology
Therapeutics, Targets, and Chemical Biology
A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice
Tumor and Stem Cell Biology
HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem–like Cells
MIF Produced by Bone Marrow–Derived Macrophages Contributes to Teratoma Progression after Embryonic Stem Cell Transplantation
RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features
Letters to the Editor
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.